11. Editorial: fixed‐dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis. Issue Volume 35:Issue S1(2021)Supplement (23rd February 2021) Authors: Lebwohl, M.; Warren, R.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Issue S1(2021)Supplement Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis. (23rd August 2021) Authors: Reich, K.; Mrowietz, U.; Menter, A.; Griffiths, C.E.M.; Bagel, J.; Strober, B.; Nunez Gomez, N.; Shi, R.; Guerette, B.; Lebwohl, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 12(2021) Page Start: 2409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study. (14th July 2021) Authors: Van Voorhees, A.S.; Stein Gold, L.; Lebwohl, M.; Strober, B.; Sofen, H.; Papp, K.; Bagel, J.; Zhang, Z.; Paris, M.; Wang, Y. Journal: British journal of dermatology Issue: Volume 185:Number 4(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study. (1st October 2021) Authors: Van Voorhees, A.S.; Stein Gold, L.; Lebwohl, M.; Strober, B.; Sofen, H.; Papp, K.; Bagel, J.; Zhang, Z.; Paris, M.; Wang, Y. Journal: British journal of dermatology Issue: Volume 185:Number 4(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. FRI0123 Clinical Outcomes Associated with Switching or Discontinuation of Anti-TNF Inhibitors for Non-Medical Reasons. (9th June 2015) Authors: Lebwohl, M.; Skup, M.; Yang, H.; Faust, E.; Kageleiry, A.; Chao, J.; Wolf, D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. FRI0272 SECUKINUMAB DEMONSTRATES A CONSISTENT SAFETY PROFILE IN PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS OVER LONG TERM: UPDATED POOLED SAFETY ANALYSES. (13th June 2020) Authors: Deodhar, A.; Mcinnes, I.; Baraliakos, X.; Reich, K.; Gottlieb, A. B.; Lebwohl, M.; Schreiber, S.; Bao, W.; Marfo, K.; Richards, H.; Pricop, L.; Shete, A.; Safi, J.; Mease, P. J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials. (4th September 2017) Authors: Guenther, L.; Warren, R.B.; Cather, J.C.; Sofen, H.; Poulin, Y.; Lebwohl, M.; Terui, T.; Potts Bleakman, A.; Zhu, B.; Burge, R.; Reich, K.; van de Kerkhof, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 11(2017) Page Start: 1867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam. (28th March 2019) Authors: Jalili, A.; Lebwohl, M.; Stein Gold, L.; Andersen, S.B.; Jensen, K.L.; Pink, A.E.; Segaert, S.; Berg, P.; Calzavara‐Pinton, P.G.; de la Cueva Dobao, P.; Thaçi, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Itch: an under‐recognized problem in psoriasis. (10th May 2019) Authors: Elewski, B.; Alexis, A.F.; Lebwohl, M.; Stein Gold, L.; Pariser, D.; Del Rosso, J.; Yosipovitch, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 8(2019) Page Start: 1465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up. (1st May 2015) Authors: Langley, R.G.; Lebwohl, M.; Krueger, G.G.; Szapary, P.O.; Wasfi, Y.; Chan, D.; Hsu, M.C.; You, Y.; Poulin, Y.; Korman, N.; Prinz, J.C.; Reich, K. Journal: British journal of dermatology Issue: Volume 172:Number 5(2015:May) Page Start: 1371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗